Omeros Quarterly Balance Sheet
NASDAQ: OMERHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Omeros financial position
As of Jun 30, 2026, Omeros reported total assets of $286.8 million, up 43.0% from a year earlier against total liabilities of $338.2 million. Shareholders' equity was negative at -$51.3 million, meaning liabilities exceed assets; this is often the result of large share buybacks or accumulated losses. The company held $2.0 million in cash and equivalents against $42.0 million of debt, a net debt position of $40.0 million.
The current ratio (current assets divided by current liabilities) was 1.95, meaning short-term assets cover obligations due within a year.
Summary generated from market data by MetaCap's automated system. Methodology
Omeros balance sheet (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 1.99M | 1.91M | 9.66M | 2.40M | 1.90M | 4.26M | 3.40M | 1.52M | 2.12M | 1.83M | 7.11M | 30.64M |
| Short-Term Investments | 129.97M | 133.41M | 162.14M | 33.69M | 26.84M | 48.15M | 86.73M | 121.64M | 156.79M | 228.50M | 164.74M | 279.67M |
| Receivables | 11.71M | 6.75M | 0 | 6.91M | 6.28M | 7.08M | 7.74M | 6.39M | 8.08M | 7.64M | 8.10M | 6.88M |
| Inventory | 842.00K | 183.00K | 0 | — | — | — | — | — | — | — | — | — |
| Total Current Assets | 185.24M | 180.35M | 215.67M | 71.81M | 69.65M | 96.18M | 134.12M | 164.92M | 202.93M | 280.96M | 217.90M | 351.34M |
| Property, Plant & Equipment | 1.38M | 1.53M | 1.77M | 2.01M | 2.24M | 2.42M | 2.68M | 1.94M | 2.03M | 1.80M | 1.95M | 1.72M |
| Total Assets | 286.83M | 286.17M | 325.63M | 185.71M | 200.57M | 235.16M | 277.08M | 313.33M | 356.31M | 437.49M | 378.27M | 493.07M |
| Accounts Payable | 6.34M | 5.37M | 4.76M | 12.50M | 8.84M | 4.41M | 5.91M | 7.72M | 6.50M | 6.18M | 7.71M | 5.87M |
| Total Current Liabilities | 94.96M | 59.44M | 78.06M | 80.76M | 85.50M | 83.22M | 79.53M | 55.62M | 59.48M | 59.06M | 53.32M | 147.18M |
| Long-Term Debt | 42.03M | 52.81M | 51.36M | 72.08M | 63.47M | 70.40M | 97.18M | 97.03M | 96.89M | 213.46M | 213.16M | 221.83M |
| Total Liabilities | 338.18M | 349.51M | 446.86M | 406.18M | 429.25M | 448.71M | 459.69M | 467.51M | 480.91M | 508.82M | 403.25M | 507.02M |
| Shareholders' Equity | -51.35M | -63.33M | -121.23M | -220.48M | -228.69M | -213.55M | -182.61M | -154.17M | -124.60M | -71.33M | -24.98M | -13.95M |
| Retained Earnings | -844.40M | -857.63M | -913.70M | -1.00B | -969.23M | -943.80M | -910.35M | -878.99M | -846.75M | -790.71M | -753.53M | -744.46M |
| Total Debt | 42.03M | 52.81M | 51.36M | 72.08M | 63.47M | 70.40M | 97.18M | 97.03M | 96.89M | 213.46M | 213.16M | 221.83M |
| Net Cash (Debt) | 89.92M | 82.51M | 120.44M | -35.99M | -34.73M | -17.99M | -7.05M | 26.13M | 62.02M | 16.87M | -41.31M | 88.48M |
| Shares Outstanding | 72.09M | 72.00M | 71.67M | 70.07M | 60.02M | 58.06M | 58.04M | 57.95M | 57.94M | 57.94M | 61.13M | 62.87M |
This table shows 12 quarterly periods of Omeros's balance sheet, from Q2 2026 back to Q3 2023, across 17 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow OMER's reporting calendar. What is a balance sheet?